Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022

BUY
$0.63 - $2.58 $115,431 - $472,720
183,225 Added 21.26%
1,045,023 $1.17 Million
Q1 2022

Apr 19, 2022

BUY
$1.65 - $3.12 $1.42 Million - $2.69 Million
861,798 New
861,798 $2.17 Million
Q4 2021

Jan 28, 2022

SELL
$2.31 - $5.85 $44,194 - $111,922
-19,132 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$4.55 - $10.36 $3.5 Million - $7.96 Million
-768,337 Reduced 97.57%
19,132 $88,000
Q2 2021

Aug 05, 2021

BUY
$5.98 - $7.51 $70,390 - $88,400
11,771 Added 1.52%
787,469 $5.42 Million
Q1 2021

May 13, 2021

BUY
$6.98 - $11.29 $4.25 Million - $6.88 Million
608,949 Added 365.19%
775,698 $5.68 Million
Q4 2020

Feb 12, 2021

BUY
$7.81 - $10.39 $342,773 - $456,006
43,889 Added 35.72%
166,749 $1.35 Million
Q3 2020

Oct 30, 2020

SELL
$6.34 - $10.83 $147,734 - $252,360
-23,302 Reduced 15.94%
122,860 $1.26 Million
Q2 2020

Aug 11, 2020

BUY
$4.6 - $8.6 $230,050 - $430,094
50,011 Added 52.01%
146,162 $979,000
Q1 2020

May 14, 2020

BUY
$3.51 - $6.17 $132,600 - $233,090
37,778 Added 64.72%
96,151 $436,000
Q4 2019

Jan 31, 2020

BUY
$5.76 - $7.35 $14,325 - $18,279
2,487 Added 4.45%
58,373 $354,000
Q3 2019

Nov 12, 2019

SELL
$6.46 - $8.37 $25,413 - $32,927
-3,934 Reduced 6.58%
55,886 $393,000
Q2 2019

Jul 30, 2019

SELL
$6.34 - $8.8 $38,661 - $53,662
-6,098 Reduced 9.25%
59,820 $389,000
Q1 2019

May 13, 2019

BUY
$6.06 - $9.0 $31,372 - $46,593
5,177 Added 8.52%
65,918 $548,000
Q4 2018

Feb 01, 2019

BUY
$5.18 - $9.35 $60,191 - $108,647
11,620 Added 23.66%
60,741 $337,000
Q3 2018

Nov 07, 2018

SELL
$6.0 - $11.35 $381,162 - $721,031
-63,527 Reduced 56.39%
49,121 $434,000
Q2 2018

Aug 07, 2018

BUY
$4.82 - $8.53 $42,869 - $75,865
8,894 Added 8.57%
112,648 $961,000
Q1 2018

May 14, 2018

BUY
$4.96 - $6.84 $370,581 - $511,043
74,714 Added 257.28%
103,754 $534,000
Q4 2017

Feb 12, 2018

BUY
$4.58 - $10.81 $133,003 - $313,922
29,040
29,040 $149,000

Others Institutions Holding RDHL

About RedHill Biopharma Ltd.


  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $557M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.